|
Status |
Public on Feb 01, 2016 |
Title |
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing Genome binding/occupancy profiling by high throughput sequencing Third-party reanalysis
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
26944678 |
|
Submission date |
Aug 24, 2015 |
Last update date |
May 15, 2019 |
Organization |
Ottawa Hospital Research Institute |
Phone |
(613) 737-8899 -73255
|
Department |
Cellular and Molecular Medicine
|
Lab |
Ottawa Bioinformatics Core Facility
|
Street address |
501 Smyth Rd.
|
City |
Ottawa |
State/province |
ON |
ZIP/Postal code |
K1H 8L6 |
Country |
Canada |
|
|
Platforms (1) |
GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
|
Samples (17)
|
GSM1859757 |
H3K27me3 ChIP-seq TAL1-KD |
GSM1859758 |
Input ChIP-seq TAL1-ctl |
GSM1859759 |
TAL1-control RNA-seq, replicate 1 |
GSM1859760 |
TAL1-control RNA-seq, replicate 2 |
GSM1859761 |
TAL1-KD RNA-seq, replicate 1 |
GSM1859762 |
TAL1-KD RNA-seq, replicate 2 |
GSM1859763 |
UTX-control RNA-seq, replicate 1 |
GSM1859764 |
UTX-control RNA-seq, replicate 2 |
GSM1859765 |
UTX-KD RNA-seq, replicate 1 |
GSM1859766 |
UTX-KD RNA-seq, replicate 2 |
GSM1859767 |
J4-control RNA-seq, replicate 1 |
GSM1859768 |
J4-control RNA-seq, replicate 2 |
GSM1859769 |
J4-2uM RNA-seq, replicate 1 |
GSM1859770 |
J4-2uM RNA-seq, replicate 2 |
|
This SuperSeries is composed of the following SubSeries: |
GSE64832 |
UTX inhibition as selective epigenetic therapy against TAL1-driven T cell acute lymphoblastic leukemia |
GSE72298 |
H3K27 methylation changes in Jurkat cells in response to TAL1-KD |
GSE72299 |
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment |
|
Relations |
BioProject |
PRJNA293693 |